Lupin Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets".
Lupin Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets".